Tech Company Financing Transactions

Arcadia Biosciences Funding Round

On 4/28/2014, Arcadia Biosciences secured $33 million in Series D funding from Mandala Capital Limited, BASF Venture Capital America and Presidio Partners.

Transaction Overview

Company Name
Arcadia Biosciences
Announced On
4/28/2014
Transaction Type
Venture Equity
Venture Equity
Amount
$33,000,000
Round
Series D
Investors

Mandala Capital Limited (Lead Investor) (Uday Garg)

BASF Venture Capital America (Keith Gillard)

Presidio Partners (David Collier)

Saints Capital (Lilian Murray)

Proceeds Purpose
Arcadia plans to use proceeds from the financing to accelerate the development and commercial launch of products based on the company's agronomic performance and product quality trait technologies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
202 Cousteau Pl. 105
Davis, CA 95618
USA
Phone
(530) 756-7077
Website
www.arcadiabio.com
Email Address
[email protected]
Overview
Arcadia Biosciences is an agricultural technology company focused on developing products that benefit the environment and human health.
Profile
Arcadia Biosciences LinkedIn Company Profile
Social Media
Arcadia Biosciences Company Twitter Account
Company News
Arcadia Biosciences News
Facebook
Arcadia Biosciences on Facebook
YouTube
Arcadia Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Matthew Plavan
  Matthew Plavan LinkedIn Profile  Matthew Plavan Twitter Account  Matthew Plavan News  Matthew Plavan on Facebook
Chief Financial Officer
Pam Haley
  Pam Haley LinkedIn Profile  Pam Haley Twitter Account  Pam Haley News  Pam Haley on Facebook
VP - Bus. Development
Sarah Reiter
  Sarah Reiter LinkedIn Profile  Sarah Reiter Twitter Account  Sarah Reiter News  Sarah Reiter on Facebook
VP - Human Resources
Chris Williams-Campbell
  Chris Williams-Campbell LinkedIn Profile  Chris Williams-Campbell Twitter Account  Chris Williams-Campbell News  Chris Williams-Campbell on Facebook
VP - Operations
Grant Aldridge
  Grant Aldridge LinkedIn Profile  Grant Aldridge Twitter Account  Grant Aldridge News  Grant Aldridge on Facebook
VP - R & D
Randall Shultz
  Randall Shultz LinkedIn Profile  Randall Shultz Twitter Account  Randall Shultz News  Randall Shultz on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/28/2014: Omedix venture capital transaction
Next: 4/28/2014: CivaTech Oncology venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.